Načítá se...
Monitoring for Response to Antineoplastic Drugs: The Potential of a Metabolomic Approach
For most cancers, chemotherapeutic options are rapidly expanding, providing the oncologist with substantial choices. Therefore, there is a growing need to select the best systemic therapy, for any individual, that effectively halts tumor progression with minimal toxicity. Having the capability to pr...
Uloženo v:
| Vydáno v: | Metabolites |
|---|---|
| Hlavní autoři: | , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
MDPI
2017
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5746740/ https://ncbi.nlm.nih.gov/pubmed/29144383 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/metabo7040060 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|